CAMBRIDGE, MA – ALS.net announced today that the annual Race 4 Research 5K and Walk will be held on Sunday, May 15, 2016 in Technology Square in Cambridge, MA. The Race 4 Research features a 5K road race and four-mile walk and also includes family activities and refreshments courtesy of local restaurants, breweries and other vendors. All proceeds from the event will benefit ALS.net and the research it funds directly at the ALS Therapy Development Institute, a nonprofit biotech whose scientists actively discover and develop treatments and a cure for amyotrophic lateral sclerosis (ALS).

“The Race 4 Research is a family-friendly event that helps to fund ALS research happening every day in our labs,” says Steve Perrin, Ph.D., CEO and CSO of ALS.net/ALS Therapy Development Institute. “Everyone who participates helps support research for this devastating disease that currently has no treatments or cure. Every dollar raised from the Race 4 Research goes directly to projects taking place in our Cambridge, MA facility, including those like the first of its kind Precision Medicine Program in ALS.”

 

The Race 4 Research will open registration at 8:30 AM. The four-mile walk will begin promptly at 9:30 AM and the 5K will begin at 10 AM. Lab tours of the ALS Therapy Development Institute’s facility will also be available to participants beginning at 12 PM.

 

To participate, donate or learn more about the Race 4 Research 5K and Walk, visit www.race4research.org.  

 

 

About ALS.net

ALS.net was born from the realization that something was needed to bring people together with a common goal to fund the research necessary to slow and stop amyotrophic lateral sclerosis (ALS). It is a global network of people with ALS, their care providers, family and friends, fundraising events, awareness campaigns and foundations committed to funding innovative, patient-centered research leading to the development of effective treatments and eventually a cure for ALS. ALS.net directly supports the ALS Therapy Development Institute, the world’s first and largest nonprofit biotech focused 100 percent on ALS research. Founded in 1999, the Institute brings together 30 industry-trained scientists with experience discovering drugs and bringing them to market. Led by people living with the disease and their families, they understand the urgent need to slow and stop this disease. For more information, visit www.als.net.